Telitacicept demonstrates high probability of efficacy in myasthenia gravis: a Bayesian real-world study

Puntos clave

• Significant symptom improvement was observed with telitacicept treatment, indicating high efficacy.
• Bayesian analysis suggests a strong likelihood of beneficial outcomes, underscoring its potential in therapy.
• The observational analysis leveraged existing patient data to evaluate treatment effectiveness in real-world settings.
• Study limitations include its retrospective design and a relatively small patient sample size, highlighting caution in broader application.